Description: Arcus is a biopharmaceutical company aiming to bring together scientists, physicians & advisors to focus on developing best-in-class cancer therapies.
Clinical Candidates Overview Anti-TIGIT domvanalimab Adenosine Axis etrumadenant quemliclustat Anti-PD-1 (zimberelimab) HIF-2⍺ Inhibitor (casdatifan) Anti-CD39 (AB598) AXL Inhibitor (AB801) Clinical Trials Clinical Trials Investigator Sponsored Expanded Access Program Publications Editorials Careers Investors & Media Overview Press Releases Events & Presentations Events Calendar Presentations Stock Information Analyst Coverage Stock Information SEC Filings Corporate Governance Governance Documents Managemen
Arcus is at the forefront of designing combination therapies, with best-in-class potential, in our relentless pursuit of cures for cancer.
ASCO News: Novel Approach with Immunotherapy in Late-Stage Colorectal Cancer Read More PORTRAITS OF CANCER: People are sharing their stories in ways they’ve never been able to before. Visit Website We are combining DISCOVERY CAPABILITIES Producing differentiated small molecules and antibodies designed to optimize combinability